📂 Drugs
IBI311 — Definition
IBI311 / IBI311
IBI311 is a drug candidate in monoclonal antibody structure. Specifically interlökin-17A (IL-17A) is developed to be used in the treatment of autoimmune and inflammatory diseases by targeting the routes. In clinical studies, activities and safety profiles are evaluated especially in cases associated with IL-17, such as psöriyazis and ankylozan spondylitis. It has not yet been released commercially and is a biological agent in the research phase.
Frequently Asked Questions
❓ What is IBI311?
IBI311; iBI311 is a drug candidate in monoclonal antibody structure. Specifically interlökin-17A (IL-17A) is developed to be used in the treatment of autoimmune and inflammatory diseases by targeting the routes. In clinical studies, activities and safety profiles are evaluated especially in cases associated with IL-17, such as psöriyazis and ankylozan spondylitis. It has not yet been released commercially and is a biological agent in the research phase.
❓ What is IBI311 in Turkish?
The Turkish equivalent of "IBI311" is IBI311.
❓ Which medical field is IBI311 related to?
This term belongs to the Drugs category.